In what Hyderabad-based Bharat Biotech claims is the largest efficacy trial in India across 25 trial sites, the company claims its Covid-19 vaccine Covaxin is 65 per cent effective against the Delta variant. In a pre-print paper that is yet to be peer-reviewed, the company claimed that the vaccine is also 63 per cent effective …
Covaxin 65% Effective Against Delta Variant, Phase 3 Study Reveals Read More »
Bharat Biotech has announced the cost of COVAXIN for State governments and Private Hospitals. It will cost 600 rupees per dose for State Governments and 1200 rupees per dose for Private Hospitals. The price of vaccine for export is 15 to 20 dollars.
Union Finance Minister has approved a total of Rupees 4,567.50 crore as advance payment to Covishield and Covaxin manufacturers Serum Institute of India (SII) and Bharat Biotech to ramp up production against coronavirus. The government has approved Rupees 3,000 crore financial assistance to SII and Rupees 1567.50 crore to Bharat Biotech which will soon be …
AIR
All preparations for the first phase of COVID vaccination have been completed. Today, 5,63,500 doses of vaccine were received by the State. Of these, 4,43,500 doses are Covishield vaccine of Serum Institute of India, while 20,000 vaccine doses are Covaxin of Bharat Biotech.